2021
DOI: 10.1097/rlu.0000000000003747
|View full text |Cite
|
Sign up to set email alerts
|

18F-FDG PET/CT of Primary Tracheal Adenoid Cystic Carcinoma

Abstract: Primary adenoid cystic carcinoma in the trachea is a very rare tumor. A 40-year-old woman presented with persisting cough and wheezing over 2 months. A CT scan showed a mass in the tracheal wall. The bronchoscopic biopsy confirmed adenoid cystic carcinoma. 18F-FDG PET/CT was performed to evaluate the tracheal mass, which showed an FDG-avid mass in the right posterior tracheal wall.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 11 publications
0
3
0
Order By: Relevance
“…At present, the clinical diagnostic means for primary tracheal tumors include physical examination, blood examination, X-ray, CT, magnetic resonance imaging (MRI), tracheography, and pathological biopsy, which often requires a combination of various results for diagnosis ( 10 , 11 ). The pathological biopsy is the gold standard for determining primary tracheal tumor, which is the most precise examination.…”
Section: Introductionmentioning
confidence: 99%
“…At present, the clinical diagnostic means for primary tracheal tumors include physical examination, blood examination, X-ray, CT, magnetic resonance imaging (MRI), tracheography, and pathological biopsy, which often requires a combination of various results for diagnosis ( 10 , 11 ). The pathological biopsy is the gold standard for determining primary tracheal tumor, which is the most precise examination.…”
Section: Introductionmentioning
confidence: 99%
“…3 Differential diagnoses for tracheal cartilage uptake include polychondritis, 10 polyangiitis with granulomatosis, 11 IgG-4-related disease, 12 tuberculosis, 13 postradiogenic necrosis, 14 or malignancies such as lymphoma, 15,16 lung cancer, 17 and adenoid cystic carcinoma. 18,19 In conclusion, owing to the widespread use of FDG PET/CT in the workup of inflammation of unknown origin, nuclear medicine physicians should be aware of possible FDG uptake patterns and commonly involved organs in the only recently established disease VEXAS syndrome. In the future, FDG PET/CT might also be used for monitoring therapy response in VEXAS syndrome.…”
mentioning
confidence: 99%
“…Such an approach could minimize false-positive PET findings erroneously interpreted as metastases. This, in particular, is a relevant limitation of the broadly used 12 but unspecific FDG 13 …”
mentioning
confidence: 99%